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An 82-year-old female with a history of hypertrophic cardiomyopathy (HCM), sick sinus syndrome (SSS), and
an implanted DDD pacemaker was admitted to our hospital for congestive heart failure caused by rapid atrial
ﬁbrillation. After administration of amiodarone, atrial ﬁbrillation (AF) became atrial ﬂutter (AFL). Electro-
physiological investigation revealed counterclockwise AFL. Catheter ablation of the cavotricuspid isthmus was
performed. Burst pacing from the coronary sinus ostium to conﬁrm the block line of the isthmus induced
rapid, regular, ventricular pacing at a rate of 110 bpm. The differential diagnosis of this tachycardia included
ectopic atrial tachycardia and pacemaker-mediated, endless loop tachycardia (ELT). We diagnosed this
arrhythmia as ELT, because temporary reprogramming of the pacemaker mode from DDD to VVI terminated
the tachycardia. In this patient, pacing parameters favored ELT (long atrioventricular delay [AVD] and short
postventricular atrial refractory period [PVARP]), and atrioventricular and ventriculoatrial conduction time
was prolonged as a result of amiodarone administration.
The ELT continued because the rate was lower than the programmed upper tracking rate. Reprogramming
the parameter (decreasing AVD and increasing PVARP) resulted in termination of ELT.
& 2012 Japanese Heart Rhythm Society. Published by Elsevier B.V. All rights reserved.1. Introduction
Endless loop tachycardia (ELT) is a well-recognized complica-
tion of dual chamber pacing systems [1,2]. Recent pacemaker
systems adopt algorithms of ELT termination given that ELT is
generally maintained at the programmed upper tracking rate. The
rate of ELT depends on the upper tracking rate, atrioventricular
delay (AVD), and ventriculoatrial (VA) conduction time. The sum
of the retrograde VA conduction time and the programmed AVD is
equal to the ELT cycle length with a rate below the upper tracking
rate [3]. In this situation, ELT does not satisfy the termination
algorithm of some pacemakers, and the tachycardia may con-
tinue. We report a case of ELT below the upper tracking rate.2. Case report
An 82-year-old female with hypertrophic cardiomyopathy
(HCM; mid-ventricular obstruction) and sick sinus syndrome
(SSS) was implanted with a DDD pacemaker 15 years prior tort Rhythm Society. Published by E
: þ81 54 252 0010.
kamoto).this admission. The pacemaker generator was replaced for con-
sumption of its battery 7 years prior (Vertus plus II, Guidant,
Indianapolis, Indiana, USA), and she was followed at our pace-
maker follow-up clinic. She experienced subjective symptoms
such as shortness of breath, palpitation, and general fatigue in
March 2011, and visited our department. Chest X-ray revealed
cardiomegaly (CTR¼68%) and lung congestion. The electrocardio-
gram (ECG) performed upon admission revealed atrial ﬁbrillation
(AF), with a heart rate of 100 bpm and a negative T-wave in
the precordial leads. We diagnosed the patient with congestive
heart failure because of rapid AF and HCM, and began treatment.
Echocardiogram showed asymmetric septal hypertrophy, a gen-
eral decline in wall motion, and an ejection fraction of 43%.
Congestive heart failure was well-controlled by the adminis-
tration of angiotensin-converting enzyme inhibitor and diuretics.
Because the patient had low cardiac function, amiodarone was
added (a loading dose of 400 mg/day) to control AF. After admin-
istration of amiodarone, AF became atrial ﬂutter (AFL). We there-
fore performed an electrophysiological study (EPS). EPS revealed
cavotricuspid isthmus (CTI)—dependent, counterclockwise AFL.
Linear ablation of the CTI was performed. Burst pacing from the
coronary sinus ostium to conﬁrm the block line of the isthmus
induced rapid, regular, ventricular pacing at a rate of 110 bpmlsevier B.V. All rights reserved.
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Fig. 1. (A) Electrocardiogram during rapid, regular ventricular pacing at a rate of 110 bpm. (B) Intracardiac electrogram during tachycardia. The earliest site of atrial
activation was the His bundle electrogram recording site.
Fig. 2. (A-1) Pacemaker telemetry data during endless loop tachycardia. (B-1) Pacemaker telemetry data during rapid ventricular pacing at 110 bpm recorded after anti-
arrhythmic drug exchange from amiodarone to aprindine hydrochloride. Endless loop tachycardia did not occur, even with the same programming parameters as before
ablation. (A-2, B-2) Pacemaker telemetry data showed shortening of the ventriculoatrial conduction time during rapid ventricular pacing at 110 bpm after anti-arrhythmic
drug exchange.
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pace sequence during the tachycardia (Fig. 2A-1). The earliest
site of atrial activation was the His bundle (HBE) recording
site (Fig. 1). This tachycardia continued for 6 min until it was
terminated by a premature atrial beat and was induced repeat-
edly. The differential diagnosis of this tachycardia included
ectopic atrial tachycardia and pacemaker-mediated endless looptachycardia (ELT). Tachycardia was terminated by reprogramming
the pacemaker mode from DDD to VVI, after which rapid atrial
activation also disappeared (Fig. 3). We diagnosed this arrhythmia
as ELT, which was conducted to the ventricle via the pacemaker
and retrogradely to the atrium via the AV node. ELT was also
induced during a standard pacemaker lead threshold-check ses-
sion after EPS and catheter ablation. Pacemaker parameters are
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Fig. 3. Tachycardia was terminated by reprogramming the pacemaker mode from
DDD to VVI; rapid atrial activation also disappeared.
Table 1
Programming data for the pacemaker. The left side shows data prior to ablation,
and the right side represents data reprogramming after ablation.
Parameter During ablation Reprogramming
after ablation
Mode DDD DDD
Lower rate limit (bpm) 60 60
Max tracking rate (bpm) 120 120
AV delay (paced) (ms) 300 220
AV delay (sensed) (ms) 270 190
PVARP (ms) Dynamic PVARP 280
Maximum 250 –
Minimum 200 –
PVARP after PVC/PAC (ms) 400 400
PVAB (ms) 80 80
PMT termination On On
Atrial sensitivity (mV) 0.75 0.75
Ventricular sensitivity (mV) 2.5 2.5
A-Tachy response On (DDI) On (DDI)
AV¼atrioventricular; PVARP¼postventricular atrial refractory period; PVC¼pre-
mature ventricular complex; PAC¼premature atrial complex; PVAB¼post ven-
tricular atrial blanking interval; PMT¼pacemaker mediated tachycardia.
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always showed A pace—V sense sequence during routine pacemaker
clinics. We have never detected an episode of AV block. The DDD
pacemaker was programmed with long AVD (paced as AVD 300ms,
sensed AVD 270ms), and dynamic post-ventricular atrial refractory
period (PVARP) mode (maximum PVARP, 250ms; minimum PVARP,
200ms). Dynamic PVARP mode is a dynamic interval designed to
provide a longer PVARP at slower rates to enhance protection against
ELT, and a shorter PVARP to enhance atrial sensing at high rates. The
upper tracking rate was 120 bpm. Pacemaker telemetry showed
250ms of retrograde VA conduction time over programmed PVARP
of approximately 208ms at 110 bpm. We reprogrammed her pace-
maker to a longer, ﬁxed PVARP (280ms), and a shorter AV delay
(220ms), to ensure an upper tracking rate of 120 bpm. After
reprogramming the pacemaker, ELT no longer occurred. Two monthslater, amiodarone was discontinued because of appetite loss. We
changed her prescription from 200mg/day amiodarone to 20mg/day
aprindine hydrochloride to control paroxysmal atrial ﬁbrillation
(PAF). Pacemaker telemetry data showed shortening of the VA
interval during rapid V-pacing at 110 bpm after the change in anti-
arrhythmic drugs (Fig. 2A-2, B-1, B-2). ELT was not induced after
rapid ventricular pacing, even with the same programming para-
meters, before catheter ablation.3. Discussion
ELT is a well-recognized complication of a dual chamber pacing
system.[1,2] This is a wide QRS tachycardia resulting from the sensing
of retrograde P-waves by the pacemaker, consequently triggering
ventricular pacing beyond the programmed PVARP. Retrograde P-
waves are induced by ectopic ventricular beats, ectopic atrial beats,
atrial sensing failure, atrial pacing failure, and long AV delay.
The incidence of retrograde VA conduction was reported in
80% of SSS cases and in 35% of AV block cases [4]. Another study
reported that the incidence of VA conduction was 32% in second
degree AV block, and 14% in complete AV block [5]. Even in
complete AV block, some patients who were implanted with a
physiological pacemaker have a risk of ELT [6].
Thus, recent physiological pacemaker generators always have an
algorithm to terminate ELT. ELT are generally maintained at the
programmed upper tracking rate of the pacemaker. The generator in
the current patient has an ELT detection algorithm. When 16
consecutive ventricular paces at the upper tracking rate are observed
following atrial sensed events with the stability of the VA interval
varying not more than 32ms, this is detected as ELT. PVARP is then
automatically extended to 500ms for 1 cardiac cycle to avoid
triggering of another ventricular event and break the ELT. In this
case, ELT persisted despite the ELT termination algorithm in the
generator. The pacemaker was functioning normally; however, the
cycle length of this tachycardia was the sum of the intrinsic VA
interval and the programmed sensed AVD, and the rate was
110 bpm—below the programmed upper tracking rate of 120ms.
Several large clinical trials have revealed that a high percentage of
ventricular pacing increases atrial ﬁbrillation and the incidence of
heart failure, thus leading to poor clinical outcome [7,8]. Recent
clinical guidelines recommend the minimization of ventricular pacing
in SSS patients. In some patients, prolonged pacemaker AVD is
selected to preserve intrinsic ventricular beats. This patient was
implanted with a DDD pacemaker because of SSS. Long AV delay
(paced AVD of 300ms, sensed AVD of 270ms) was programmed to
preserve intrinsic ventricular beats. During 100 ppm burst pacing
from the coronary sinus ostium to conﬁrm the block line of the
isthmus, the Wenckebach phenomenon occurred. When the AV
interval was prolonged relative to the programmed AVD, ventricular
pacing began, and VA conduction beyond the atrial refractory period
occurred, which initiated the ELT.
The programmed upper tracking rate is regulated by the sum
of programmed AVD and PVARP. A low upper tracking rate causes
a 2-to-1 AV block, or Wenckebach phenomenon, at a high sinus
rhythm rate during exercise. The dynamic PVARP mode of this
pacemaker is a dynamic interval designed to provide a longer
PVARP at slower rates to enhance protection against ELT, and a
shorter PVARP to enhance atrial sensing at higher rates. In this
patient, dynamic PVARP mode (maximum PVARP, 250 ms; mini-
mum PVARP, 200 ms) was selected to generate a higher upper
tracking rate (120 bpm) just after generator replacement. The
paced VA interval during ELT was approximately 250 ms, as
revealed from pacemaker telemetry data. The ELT rate was
110 ppm and PVARP at this pacing rate with dynamic PVARP
mode was 208 ms—below the paced VA interval. These reasons
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tion algorithm.
Prolonging PVARP to prevent sensing of the retrograde P wave
is a well-known method to prevent ELT. We selected this method
and succeeded in controlling the ELT. Prolonging PVARP affects
the upper tracking rate of the pacemaker, which is determined by
the sum of AV delay and PVARP. To ensure an adequate upper
tracking rate with a long AV delay, the available width of the
PVARP is limited. If ELT is to recur in this patient, and adjustment
of the PVARP fails, reprogramming the pacemaker mode from
DDD to DDI may be an effective option. In SSS patients, changing
the pacing mode to DDI may be a simple and deﬁnitive strategy to
avoid ELT.
The majority of anti-arrhythmic drugs cause block or depres-
sion of AV and VA conduction. Amiodarone has a strong effect of
prolonging AV and VA conduction among anti-arrhythmic drugs
[9]. Some reports suggested that anti-arrhythmic medication
may be considered for patients with an ELT event to create a VA
conduction block [9]. But in this case, introduction of amiodarone
was the trigger of ELT initiation by prolonging VA conduction
to the point that it fell beyond the PVARP. Replacement of the
pacemaker generator was performed 7 years before this admis-
sion. Programming of the device was not changed from the time of
generator exchange, but there was no episode of ELT before the
initiation of amiodarone. After changing the patient’s prescription
from amiodarone to aprindine hydrochloride, her pacemaker
telemetry data showed shortening of the VA interval during rapid
V-pacing at 110 ppm (Fig. 2A-2, B-1 and B-2). ELT was not induced
after rapid ventricular pacing, even with the same programming
parameters as before catheter ablation.
In summary, programmed long AVD, prolonged VA conduction
time caused by anti-arrhythmic medication, and the rate of ELT
(110 bpm, below the upper tracking rate of 120 bpm) were thereason ELT continued even in the presence of a programmed ELT
termination algorithm. Physicians who manage patients with DDD
pacemakers should be aware that ELT does not always occur at the
upper tracking rate and recognize the risk of ELT below the upper
tracking rate in patients with programmed long AVD to avoid
ventricular pacing. The ELT rate, which is determined by retro-
grade VA conduction time, may be affected by anti-arrhythmic
drugs such as amiodarone.Conﬂict of interest
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